Enter the first few characters of Company and click 'Go'
Quarterly Results of Marksans Pharma Ltd. Company(Figures in Rs crores)
|
|
Dec 31, 2023 |
Sep 30, 2023 |
Jun 30, 2023 |
Mar 31, 2023 |
Dec 31, 2022 |
Net Sales / Income |
241.36 |
204.67 |
182.04 |
153.04 |
172.75 |
Other Income |
1.32 |
15.93 |
32.62 |
4.30 |
15.71 |
Net Profit/Loss |
25.29 |
31.29 |
44.19 |
17.81 |
25.62 |
Raw Material |
117.16 |
102.83 |
82.80 |
85.36 |
82.88 |
Power And Fuel |
0 |
0 |
0 |
0 |
0 |
Employee Expenses |
20.47 |
18.23 |
16.93 |
15.42 |
13.79 |
Excise |
|
|
|
|
|
Admin And Selling Expenses |
0 |
0 |
0 |
0 |
0 |
Research And Devlopment Expenses |
0 |
0 |
0 |
0 |
0 |
Expenses Capitalised |
0 |
0 |
0 |
0 |
0 |
Other Expenses |
63.22 |
52.21 |
53.31 |
36.94 |
51.16 |
Provisions Made |
0 |
0 |
0 |
0 |
0 |
Interest |
0.27 |
0.23 |
0.26 |
0.66 |
0.85 |
Gross Profit |
43.03 |
53 |
59.12 |
26.35 |
38.68 |
Depreciation |
8.43 |
8.50 |
4.72 |
3.51 |
4.18 |
Taxation |
9.31 |
13.21 |
10.20 |
5.04 |
8.88 |
Extra Ordinary Item |
0 |
0 |
0 |
0 |
0 |
Prior Year Adjustments |
0 |
0 |
0 |
0 |
0 |
Equity Capital |
45.32 |
45.32 |
45.32 |
45.32 |
40.30 |
Equity Dividend Rate |
0 |
0 |
0 |
0 |
0 |
Agg.Of Non-Prom. Shares (in lacs) |
0 |
0 |
0 |
0 |
0 |
Agg.Of Non PromotoHolding (%) |
0 |
0 |
0 |
0 |
0 |
EPS (in Rs.) |
0.56 |
0.69 |
0.98 |
0.39 |
0.64 |
|
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article